This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gee, J. M. Articles by Becker, K. J. Search for Related Content PubMed PubMed Citation Articles by Gee, J. M. Articles by Becker, K. J. Related Collections Acute Cerebral Infarction Behavioral Changes and Stroke Neuroprotectors Other Stroke Treatment - Medical

(Stroke. 2007;38:783.)
© 2007 American Heart Association, Inc.

Adaptive Immunity: Introduction

Lymphocytes

Potential Mediators of Postischemic Injury and Neuroprotection

J. Michael Gee, BS; Angela Kalil, BS; Connor Shea, BS Kyra J. Becker, MD

From the Harborview Medical Center, University of Washington School of Medicine, Seattle.

Correspondence to Kyra J. Becker, MD, Box 359775, Harborview Medical Center, 325 9th Ave, Seattle, WA 98104-2499. E-mail kjb{at}u.washington.edu

Abstract

Antigen-nonspecific inflammation appears to contribute to postischemic brain injury. Because there is a breach in the integrity of the blood-brain barrier after stroke, the immune system encounters novel central nervous system (CNS) antigens that allow for the development of a CNS antigen-specific autoimmune response. The nature of the immune response generated on antigen encounter is determined by the microenvironment at the site of antigen encounter. For instance, a systemic inflammatory response, such as that which would accompany an infection, could alter the microenvironment in such a way as to promote the initiation of deleterious autoimmunity. If patients who develop an infection in the immediate poststroke period are predisposed toward a CNS autoimmune response, it might help to explain why infection after stroke is associated with increased disability. We present data to support this hypothesis and to show that the breach in the blood-brain barrier can also be capitalized on to modulate the immune response to create a neuroprotective environment after stroke.

Key Words: immune response • inflammation • stroke • tolerance • lipopolysaccharide • myelin basic protein

This article has been cited by other articles:

				S. Subramanian, B. Zhang, Y. Kosaka, G. G. Burrows, M. R. Grafe, A. A. Vandenbark, P. D. Hurn, and H. Offner Recombinant T Cell Receptor Ligand Treats Experimental Stroke Stroke, July 1, 2009; 40(7): 2539 - 2545. [Abstract] [Full Text] [PDF]

				T Molnar, A Peterfalvi, L Szereday, G Pusch, L Szapary, S Komoly, L Bogar, and Z Illes Deficient leucocyte antisedimentation is related to post-stroke infections and outcome J. Clin. Pathol., November 1, 2008; 61(11): 1209 - 1213. [Abstract] [Full Text] [PDF]